Latest News September 2010 Day : 1 RANBAXY SETS UP NEW MANUFACTURING FACILITY IN SOUTH AFRICA August 2010 Day : 12 RANBAXY ACHIEVES USD 1 BILLION REVENUE AND USD 282 MN PAT FOR H1’2010. AFTER RECORD Q1 SALES, Q2 GROWTH AT 22% RANBAXY BOARD ANNOUNCES CHANGE IN EXECUTIVE LEADERSHIP July 2010 Day : 21 DAIICHI SANKYO TO LEVERAGE RANBAXY’S NETWORK TO MARKET ITS INNOVATIVE ANTIBIOTIC TAVANIC® (LEVOFLOXACIN) IN ROMANIA AND SOUTH AFRICA Day : 2 DAIICHI SANKYO AND RANBAXY TO INTEGRATE NEW DRUG RESEARCH AND DEVELOPMENT SYSTEM June 2010 Day : 10 RANBAXY LAUNCHES ANTIPLATELET AGENT PRASUGREL IN INDIA Day : 8 RANBAXY LAUNCHES GENERIC ATORVASTATIN, ‘LIPOGEN’, A CHOLESTEROL-REDUCING MEDICATION IN SOUTH AFRICA May 2010 Day : 21 RANBAXY LAUNCHES ATORVASTATIN, CHOLESTEROL-REDUCING MEDICATION INTO THE CANADIAN HEALTHCARE SYSTEM Day : 11 RANBAXY DELIVERS QUARTERLY SALES OF OVER USD 500 MN FOR THE FIRST TIME RECORDS PROFIT AFTER TAX OF USD 210 MN March 2010 Day : 29 RANBAXY AND Pfenex ANNOUNCE COLLABORATION FOR THE DEVELOPMENT OF A BIOSIMILAR THERAPEUTIC PROTEIN Read more news from Ranbaxy >
Read more news from Ranbaxy >
